How big pharma and regulators fail clinicians

Chris Bateman


Generalists daily make poor evidence-based decisions because regulatory and ethics committees fail them and drug companies habitually misrepresent products. The pervasiveness of this perversion – at least overseas – is best illustrated by the equivalent of R131.4 billion in healthcare fraud settlements made by pharmaceutical corporates in the USA over the last 10 years, with the most recent individual company fines breaking all records. 

Author's affiliations

Chris Bateman, HMPG

Full Text



pharma; clinicians; regulators

Cite this article

South African Medical Journal 2013;103(7):440-441. DOI:10.7196/SAMJ.7099

Article History

Date submitted: 2013-05-30
Date published: 2013-06-05

Article Views

Abstract views: 2004
Full text views: 3244

Comments on this article

*Read our policy for posting comments here